Printer Friendly

BIOJECT SECONDARY OFFERING PROCEEDS

 PORTLAND, Ore., Nov. 2 /PRNewswire/ -- Bioject Medical Technologies Inc. (NASDAQ: BJCT) today announced its public offering of 2,610,000 shares of common stock at $4.50 per share. The company has granted the underwriter an option to purchase up to 391,500 additional shares to cover overallotments, if any.
 Pacific Growth Equities served as underwriter for the offering. Requests for copies of the prospectus should be directed to Pacific Growth Equities, 353 Sacramento St., 16th Floor, San Francisco, CA 94111, Attn: Syndicate Department. The telephone number for Pacific Growth Equities is 415-274-6800.
 Bioject is an Oregon corporation that develops, manufacturers and markets a jet injection system for needle-free drug delivery. Using this technology for injections virtually eliminates the associated risk of contaminated needlestick injuries and related bloodborne pathogen transmission, a major concern throughout the healthcare industry. Additionally, the company is developing a self-injection system for insulin delivery pursuant to an agreement with Eli Lilly and Co., and is seeking relationships with pharmaceutical companies to develop a prefilled configuration of the company's single-use disposable syringe.
 -0- 11/2/93
 /CONTACT: Dan Zenka, APR, or Tim Justice of Bioject, 503-639-7221/
 (BJCT)


CO: Bioject Medical Technologies Inc., Pacific Growth Equities ST: Oregon IN: MTC SU: OFR

RB-JH -- SE003 -- 9466 11/02/93 07:47 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 2, 1993
Words:213
Previous Article:RADISSON RESORTS ANNOUNCES 1993-94 SKI PACKAGES
Next Article:HILLHAVEN COMPLETES REVERSE STOCK SPLIT AND BEGINS TRADING ON NEW YORK STOCK EXCHANGE
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters